James N. Woody - 15 Dec 2023 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role
Chief Executive Officer, Director
Signature
/s/ James N. Woody
Issuer symbol
ATNF
Transactions as of
15 Dec 2023
Net transactions value
+$4,700
Form type
4
Filing time
18 Dec 2023, 16:15:16 UTC
Previous filing
08 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATNF Common Stock Purchase $4,700 +25,000 +60% $0.1880 66,888 15 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective on December 15, 2023, Dr. James N. Woody, the Chief Executive Officer of the Issuer, purchased 25,000 shares of common stock of the Issuer from Prof. Sir Marc Feldmann, the Co-Executive Chairman of the Issuer, in a private transaction, for $4,720 or $0.188 per share, the closing sales price of the Issuer's common stock on such effective date.